Logo-FONAR_red.jpg
FONAR Announces Fiscal 2017 Year-End Earnings
September 14, 2017 07:30 ET | FONAR Corporation
23% Increase of Fiscal 2017 Diluted Net Income per Common Share available to Common Shareholders to $2.92, versus prior year26% Increase of Fiscal 2017 Net Income to $23.7 million, versus prior...
Leonard Marshall - Superbowl Trophy-Courtesy of Leonard Marshall
NFL Legend Tackles Chronic Traumatic Encephalopathy (CTE) with help from Cannabidiol (CBD)
April 13, 2017 09:30 ET | Elixinol
DENVER, April 13, 2017 (GLOBE NEWSWIRE) -- Super Bowl champion Leonard Marshall has renewed vigor since he stopped taking synthetic prescription drugs for CTE and started taking organic cannabidiol...
FONAR Subsidiary HMCA Acquires Another MRI Imaging Center, Bringing Total to 26
April 04, 2017 08:00 ET | FONAR Corporation
MELVILLE, N.Y., April 04, 2017 (GLOBE NEWSWIRE) -- FONAR Corporation (NASDAQ:FONR), The Inventor of MR Scanning™, reported today that its subsidiary Health Management Company of America, LLC (HMCA)...
Neuropathix_Logo_wTag.png
Kannalife Sciences Announces Publication of “Discovery of KLS-13019, a Cannabidiol-Derived Neuroprotective Agent, With Improved Potency, Safety and Permeability”
February 16, 2016 11:15 ET | Kannalife, Inc.
NEW YORK, Feb. 16, 2016 (GLOBE NEWSWIRE) -- Kannalife Sciences, Inc. (“Kannalife”), a Phyto-Medical Company, is pleased to announce the publication of the body of science behind KLS-13019, one of...
Neuropathix_Logo_wTag.png
Kannalife Sciences Announces Publication of “Discovery of KLS-13019, a Cannabidiol-Derived Neuroprotective Agent, With Improved Potency, Safety and Permeability”
February 16, 2016 11:15 ET | Kannalife, Inc.
NEW YORK, Feb. 16, 2016 (GLOBE NEWSWIRE) -- Kannalife Sciences, Inc. (“Kannalife”), a Phyto-Medical Company, is pleased to announce the publication of the body of science behind KLS-13019, one of...
Medical Marijuana Inc Primary
Medical Marijuana, Inc. and Kannalife Sciences, Inc. Announce Joint Effort to Raise Awareness for CTE Research
December 22, 2015 13:57 ET | Medical Marijuana Inc
NEW YORK, Dec. 22, 2015 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc. (OTC Pink:MJNA) is proud to announce to shareholders and the public a joint effort with investment portfolio company Kannalife...
Neuropathix_Logo_wTag.png
Kannalife Sciences, Inc. and Gridiron Cannabis Coalition, LLC Sign Binding Memorandum of Understanding
December 21, 2015 09:00 ET | Kannalife, Inc.
NEW YORK, Dec. 21, 2015 (GLOBE NEWSWIRE) -- Kannalife Sciences, Inc., a Phyto-Medical Company (“Kannalife”), announced the signing of a binding memorandum of understanding with Gridiron Cannabis...
Medical Marijuana Inc Primary
Medical Marijuana, Inc.’s Portfolio Company KannaLife’s Spokesman, Ex-NFL Star Marvin Washington to Appear on ESPN’s Outside the Lines
December 18, 2015 09:00 ET | Medical Marijuana Inc
NEW YORK, Dec. 18, 2015 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc. (OTC Pink:MJNA) is proud to announce to shareholders and the public that investment portfolio company KannaLife Sciences’...
Medical Marijuana Inc Primary
Retired NFL Star Marvin Washington Leads the Charge in "Show Your Green" – A Kannalife and Medical Marijuana, Inc. PSA and Awareness Campaign for CTE Research
December 10, 2015 09:00 ET | Medical Marijuana Inc
NEW YORK, Dec. 10, 2015 (GLOBE NEWSWIRE) -- To address the public’s questions about CTE, what the disease is and who it impacts — Medical Marijuana, Inc. (OTC Pink:MJNA) and its portfolio company...
Medical Marijuana Inc Primary
Photo Release -- Medical Marijuana, Inc.'s HempMeds Sponsors San Diego Cannabis Professionals Cup
August 03, 2015 09:00 ET | Medical Marijuana Inc
SAN DIEGO, Aug. 3, 2015 (GLOBE NEWSWIRE) -- San Diego's HempMeds™ is proud to announce its support for the cannabis industry as a presenting sponsor at the 1st annual San Diego Cannabis...